Auto Immune Disease Diagnostics Market – Size, Outlook, Trends and Forecast (2024 – 2032)

Chapter 1 Introduction
    1.1 Executive Summary
    1.2 Market Definition
    1.3 Scope of the Study
Chapter 2 Research Methodology
    2.1 Secondary Research
    2.2 Primary Research
    2.3 Analytic Tools and Model
    2.4 Economic Indicator
            2.4.1 Base Year, Base Currency, Forecasting Period
    2.5 Expert Validation
    2.6 Study Timeline
Chapter 3 Market Analysis
    3.1 Industry Value Chain Analysis
    3.2 Porter's Five Analysis
            3.2.1 Bargaining Power of Buyers
            3.2.2 Bargaining Power of Suppliers
            3.2.3 Threats of Substitutes
            3.2.4 Threats of New Entrants
            3.2.5 Industry Rivalry
    3.3 Pestle Analysis
            3.3.1 Political
            3.3.2 Economical
            3.3.3 Social
            3.3.4 Technological
            3.3.5 Legal
            3.3.6 Environmental
    3.4 SWOT Analysis
            3.4.1 Strengths
            3.4.2 Weakness
            3.4.3 Opportunities
            3.4.4 Threats
    3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
    4.1    Drivers
    4.2   Restraints
    4.3   Opportunities
    4.4   Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6  Market Segmentation by Localized disease diagnostic  type:
    6.1  Type 1 Diabetes
    6.2 Hashimoto Thyroiditis
Chapter 7  Market Segmentation by Systematic disease diagnostic type:
    7.1 Multiple sclerosis
    7.2 Systematic lupus erythematosus
    7.3 Rheumatoid  Arthritis
    7.4 Psoriasis
Chapter 8  Market Segmentation by Test type
    8.1 Urinalysis
    8.2 Total blood count
    8.3  Autoantibody test
    8.4  C-reactive protein test,
    8.5  Erythrocyte sedimentation rate,
Chapter 9  Market Segmentation by End-user type
    9.1 Labs and research centres
    9.2 Hospitals
Chapter 10  Market Segmentation by geography
    10.1 North America
            10.1.1 Introduction
            10.1.2 United States
            10.1.3  Canada
            10.1.4 Mexico
            10.1.5 Others
    10.2 Europe
            10.2.1 Introduction
            10.2.2  Spain
            10.2.3  UK
            10.2.4  Russia
            10.2.5 France
            10.2.6 Italy
            10.2.7 Others
    10.3 Asia-Pacific
            10.3.1 Introduction
            10.3.2 India
            10.3.3 China
            10.3.4 Japan
            10.3.5 Others
    10.4 The Middle East and Africa
            10.4.1  Saudi Arabia
            10.4.2 South Africa
            10.4.3 Others
Chapter 11 Competitive Landscape
    11.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
    11.2 Market Share Analysis
    11.3 Strategies Adopted By Top Companies
Chapter 12 Company Profile
    12.1 Beckman Coulter, Inc.
            12.1.1 Introduction
            12.1.2 Company overview
    12.13 Financial  Performance
    12.14 Product Benchmarking
    12.2 SQI Diagnostics, Inc.
    12.3 EUROIMMUN AG
    12.4 AESKU  Diagnostics GmbH & Co. KG
    12.5 F. Hoffmann-La Roche Ltd
    12.6 Quest Diagnostics
    12.7  Abbott Laboratories
    12.8 Siemens Healthiness
    12.9 Roche Diagnostics
    12.10 INOVA Diagnostics Inc.
    12.11 Bio Merieux SA
    12.12 Crescendo Bioscience Inc.
    12.13 Hemagen Diagnostics Inc.
    12.14 Bio-Rad Laboratories Inc.
    12.15 Orgentec
Chapter 13  Market Estimates and Forecast
    13.1 Market Estimation and Forecast 2018-2024(USD Million)
            13.1.1 Market Estimation and Forecast by Systematic disease diagnostic Type 2018-2024(USD Million)
            13.1.2 Market Estimates and Forecast by Localized disease diagnostic Type 2018-2024 (USD Million)
            13.1.3 Market Estimates and Forecast by Test type 2018-2024 (USD Million)
            13.1.4 Market Estimates and Forecast by End-user type 2018-2024(USD Million)
            13.1.5 Market Estimates and Forecast by Geography 2018-2024 (USD Million)
            13.1.6 Market Estimates and Forecast by Company 2018-2024(USD Million)
Chapter 14 Market Insights
    14.1 Insights of Industry Experts
    14.2 Investment  Opportunities
    14.3 Analyst Opinion
Chapter 15  Appendix
    15.1 List of Tables
    15.2 List of Figures